Skip to Main

Search

Results 1,791 to 1,800 of 10,000 for ""

Prosthetics-Orthotics Review Course: School of Health Professions - UT Southwestern, Dallas, TX

https://shp.utsouthwestern.edu/training/limb-prosthetics-review/

UTSW's Prosthetics-Orthotics Program has designed the lectures and exercises of the Review Course to be self-paced and easily completed in a few sessions.

Global Opportunities: School of Health Professions, Dallas, Texas

https://shp.utsouthwestern.edu/training/global/

Global Opportunities Global Opportunities Dallas Life Back-to top

Orthopaedic Physical Therapy Residency: School of Health Professions - UT Southwestern, Dallas, TX

https://shp.utsouthwestern.edu/programs/x-orthopedic-physical-therapy/

UT Southwestern’s Orthopaedic Physical Therapy Residency Program is ideal for licensed clinicians who want to achieve a higher level of training and expertise.

Prosthetics-Orthotics Residency: School of Health Professions - UT Southwestern, Dallas, TX

https://shp.utsouthwestern.edu/programs/x-prosthetics-orthotics-residency/

The UT Southwestern School of Health Professions offers one-year residency programs in prosthetics or orthotics that meet national standards.

Neurological Physical Therapy Residency Program: School of Health Professions - UT Southwestern, Dallas, TX

https://shp.utsouthwestern.edu/training/neurological-physical-therapy/

The Department of Physical Therapy offers a one-year Neurological Physical Therapy Residency Program accredited by the American Physical Therapy Association.

About The Program: Cardiovascular & Pulmonary Physical Therapy Residency Program: SHP - UT Southwestern, Dallas, Texas

https://shp.utsouthwestern.edu/training/cardiovascular-pulmonary/about-the-program.html

The Cardiovascular & Pulmonary Physical Therapy Residency Program occurs over a 12-month employment period beginning the first Monday in August. The structure includes approximately 28 hours of clinical service per week at Clements University Hospital under the supervision of clinical mentors with an additional four hours reserved for collaborative patient care with a member of the residency faculty. Additionally, formal didactic content is delivered both via self-paced online training as well as through instructor led classroom training.

UTSW builds AI-driven system to improve data collection : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-ai-model-speeds-medical-data-extraction.html

A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could dramatically reduce the time needed to create analysis-ready data for research studies.

Children’s Research Institute scientists uncover unique pathway tumors use to acquire antioxidant lipids: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-cri-utsw-pathway-tumors-antioxidant-lipids.html

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive stress, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Nature.

Artificial intelligence predicts kidney cancer therapy response: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/april-ai-kidney-cancer-therapy.html

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that’s only effective in some cases.

Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-kidney-cancer-drug.html

Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at UTSW, could offer hope to patients who develop this condition.